Results 21 to 30 of about 6,753 (182)
De Novo Psychiatric Disorders in a Woman With Giant Prolactinoma Treated With Cabergoline
Clinical Medicine Insights: Case Reports, 2023 Dopamine agonists are the first-line treatment of prolactinomas. The risk of developing de novo psychiatric symptoms during dopamine agonist therapy is low.
Chayma Belhadj Slimane +4 more
doaj +1 more source
Middle East Fertility Society Journal, 2011 Background: Prophylactic use of dopamine agonist has been associated with a decrease in the severity of ovarian hyperstimulation syndrome (OHSS). Objective: To compare cabergoline with cabergoline plus I.V albumin or I.V albumin alone in prevention of ...
Badeea S. Soliman
doaj +1 more source
Cabergoline-associated valvulopathy of the tricuspid valve in the treatment of prolactinoma
Endocrine Oncology, 2023 Cabergoline-associated valvulopathy (CAV) is defined by the echocardiographic triad of moderate or severe regurgitation, valvular thickening and restricted valvular motion.
Annabelle G Hayes +4 more
doaj +1 more source
Novel Medicine for Endometriosis and Its Therapeutic Effect in a Mouse Model
Biomedicines, 2020 Current therapeutic medicines for endometriosis cannot be administered during assisted reproductive technology (ART) because they have bad effects during pregnancy.
Young Sang Kim +5 more
doaj +1 more source
Comparison of Cabergoline and Quinagolide in Prevention of Severe Ovarian Hyperstimulation Syndrome among Patients Undergoing Intracytoplasmic Sperm Injection [PDF]
International Journal of Fertility and Sterility, 2018 Background The aim of the current study is to compare quinagolide with cabergoline in prevention of ovarian hyperstimulation syndrome (OHSS) among high risk women undergoing intracytoplasmic sperm injection (ICSI).
Robabeh Taheripanah +3 more
doaj +1 more source
Saudi Pharmaceutical Journal, 2023 Background: There is evidence that vaginal cabergoline can help to prevent ovarian hyperstimulation syndrome. Therefore, the vaginal suppository may be a good choice because it can be administered directly into the vagina and has no adverse effects on ...
Pouria Rahmanian-Devin +3 more
doaj +1 more source
Journal of Applied Animal Research, 2020 Pregnancy termination is a required procedure in companion animal practice. In healthy bitches with confirmed pregnancy, good results are obtained with the combination of prostaglandin F2 and dopamine agonist, followed by regular sonographic examination ...
Branimira Špoljarić +10 more
doaj +1 more source
Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy
ESC Heart Failure, 2023 Aims Peripartum cardiomyopathy (PPCM) is a rare heart disease, occurring in previously heart‐healthy women during the last month of pregnancy or the first months after delivery due to left ventricular (LV) systolic dysfunction.
Tobias J. Pfeffer +12 more
doaj +1 more source
Arthritis &Rheumatology, EarlyView.Objectives The aim of this study is to generate hypotheses about unknown drugs associated with the onset or worsening of Raynaud's phenomenon (RP) and to explore their potential pathophysiologic mechanisms through a mixed disproportionality/clustering analysis from the World Health Organization (WHO) pharmacovigilance database.
Alex Hlavaty +4 more
wiley +1 more source
Cabergoline-induced tricuspid regurgitation: Case report and review of literature
Indian Journal of Endocrinology and Metabolism, 2011 The increased risk of cardiac valve disease in patients treated for Parkinson′s disease with cabergoline has raised concerns about the safety of treatment with ergot-derived dopamine agonists in patients with endocrine diseases, especially prolactinoma ...
Mohammad Hayat Bhat +4 more
doaj +1 more source